RIVANNA receives FDA 510(k) clearance for Accuro XV musculoskeletal ultrasound imaging system

CHARLOTTESVILLE, Va., May 7, 2026 /PRNewswire/ -- RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Accuro® XV Diagnostic Ultrasound System. The clearance marks a...